Daktacort 2% / 1% w/w cream

Daktacort is a well-known medicated topical treatment used primarily for skin conditions that are inflamed and fungal in nature, such as athlete's foot or sweat rash. It contains a dual-action formula featuring miconazole nitrate (an antifungal) and hydrocortisone (a mild corticosteroid to reduce inflammation and itching).

The brand was originally developed by Janssen Pharmaceutica, a company founded in Belgium by Dr. Paul Janssen, who was a pioneer in modern pharmacology. Today, the brand remains under the umbrella of the Janssen Pharmaceutical Companies, which is a major subsidiary of the American multinational corporation Johnson & Johnson. Manufacturing for Daktacort occurs in various global facilities to meet international demand, though major European supply chains often utilize production sites in Belgium and Italy.

In the United Kingdom, the product is distributed and managed by Janssen-Cilag Ltd, which handles the regulatory compliance and commercial operations for the brand within the local market. As an established name in dermatology, Daktacort continues to be a staple in both over-the-counter and prescription medical sectors.